C18 dihydro Ceramide (d18:0/18:0) T35807
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 2304-80-5 | 面议 | 询底价 |
25 mg | 2304-80-5 | 面议 | 询底价 |
5 mg | 2304-80-5 | ¥3,450.00 | 询底价 |
Product Introduction
Bioactivity
英文名: C18 dihydro Ceramide (d18:0/18:0)
描述: C18 dihydro Ceramide is a bioactive sphingolipid and precursor in the de novo synthesis of C18 ceramide that lacks the 4,5-trans double bond. [1] Increased C18 dihydroceramide lipid levels lead to increased triacylglycerol storage and autophagosome accumulation as well as upregulation of the fibrosis markers α-SMA and FGF2 in Chang and LX-2 liver cells. C18 dihydro Ceramide is elevated in the plasma of pre-diabetics up to 9 years prior to the onset of type 2 diabetes. [2] It is also elevated in the skin of patients with lesional atopic dermatitis.[3]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : Soluble
Ethanol : Warmed
关键字: d18:0/18:0 | C18 dihydro Ceramide | C-18 dihydro Ceramide (d18:0/18:0)
C18 dihydro Ceramide (d18:0/18:0) T35807信息由TargetMol中国为您提供,如您想了解更多关于C18 dihydro Ceramide (d18:0/18:0) T35807报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途